Movement Alert|Veracyte Intraday Rise 6.48% in Regular Trading, shares rebound after analysts maintained constructive ratings

Market Focus
11/11

On November 11, Veracyte rose 6.48% in Regular Trading, trading at $25.5 per share, with turnover of $6.8761 million.

The move followed analyst commentary that kept a constructive stance on the stock, including a maintained Overweight rating and continued Buy recommendations even after recent target-price cuts, supporting a rebound after the sharp post-earnings selloff.

Background context shows Veracyte reported third-quarter revenue of $151.8 million and adjusted EPS of $0.51, both above market expectations. However, the company narrowed full-year revenue guidance to $590 million to $593 million and lowered its testing-revenue outlook, which had triggered a steep decline earlier in the week. More recently, one firm downgraded the stock to Market Perform with a $35 target, while other firms reduced targets but kept positive ratings, indicating that the latest rise appears more consistent with sentiment repair than a change in operating fundamentals.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10